dalteparin has been researched along with Cancer of Skin in 7 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Debergh, I | 1 |
Van Damme, N | 1 |
Pattyn, P | 1 |
Peeters, M | 1 |
Ceelen, WP | 1 |
Niedźwiedź, M | 1 |
Żebrowska, A | 1 |
Lesiak, A | 1 |
Narbutt, J | 1 |
Skibińska, M | 1 |
Schaal, JV | 1 |
Benhamou, D | 1 |
Boyer, K | 1 |
Mercier, FJ | 1 |
Schliep, S | 1 |
Kiesewetter, F | 1 |
Simon, M | 1 |
Grupp, C | 1 |
Heinzerling, L | 1 |
Ali, H | 1 |
Bennett, DD | 1 |
Muchard, L | 1 |
Kerk, N | 1 |
Strozyk, EA | 1 |
Pöppelmann, B | 1 |
Schneider, SW | 1 |
Alam, M | 1 |
Goldberg, LH | 1 |
7 other studies available for dalteparin and Cancer of Skin
Article | Year |
---|---|
The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model.
Topics: Animals; Anticoagulants; Blood Flow Velocity; Cricetinae; Erythrocytes; Immunoenzyme Techniques; Mel | 2010 |
Enoxaparin-induced eruptive angiokeratomas.
Topics: Angiokeratoma; Enoxaparin; Humans; Skin Neoplasms | 2023 |
[Parkes-Weber syndrome and pregnancy: anaesthetic implications].
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Anticoagulants; Arteriovenous Malformations; Emb | 2013 |
Drug-induced dilemma: angiokeratomas and decreased renal function.
Topics: Aged, 80 and over; Angiokeratoma; Anticoagulants; Drug Eruptions; Enoxaparin; Female; Humans; Renal | 2014 |
An eruption of angiokeratomas in the setting of enoxaparin injections.
Topics: Angiokeratoma; Drug Eruptions; Enoxaparin; Female; Fibrinolytic Agents; Humans; Middle Aged; Skin Ne | 2016 |
The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells.
Topics: Anticoagulants; Cell Line, Tumor; Endothelial Cells; Enoxaparin; Flow Cytometry; Heparin; Heparin, L | 2010 |
Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy.
Topics: Aged; Anticoagulants; Aspirin; Carcinoma, Basal Cell; Clopidogrel; Drug Administration Schedule; Fem | 2002 |